News

June 4, 2020June 4, 2020

Stem Cell Therapy Benefits Patients with Severe Inflammation, Trial Data Show

News

Remestemcel-L, Mesoblast’s lead candidate stem cell therapy for inflammatory diseases, improves lung function and exercise capacity in people with chronic obstructive pulmonary disease (COPD) and a high degree of inflammation, ... Read more

June 2, 2020June 2, 2020

COPD, Smoking Increase Death Risk in COVID-19 Patients, Study Says

News

Smokers and people with chronic obstructive pulmonary disease (COPD) are more likely to develop severe complications and die from COVID-19 infections than infected patients who do not smoke or have ... Read more

May 28, 2020May 28, 2020

Overweight COPD Patients at Greater Risk of Contracting COVID-19, Study Suggests

News

People with chronic obstructive pulmonary disease (COPD) who are overweight have increased levels of the protein that the SARS-CoV-2 virus — the virus that causes COVID-19 — uses to get ... Read more

May 21, 2020May 21, 2020

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

News

Chronic obstructive pulmonary disease (COPD) is linked to a higher risk of lung cancer in people who never smoked. In fact, their risk is equivalent to current or former ... Read more

May 14, 2020May 14, 2020

Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

News

Pulmonx’s Zephyr Endobronchial Valve significantly reduces breathlessness and improves physical activity and quality of life in people with severe emphysema, a post-hoc analysis of clinical trial data shows. The ... Read more

May 7, 2020May 7, 2020

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

News

People with chronic obstructive pulmonary disease (COPD) have three unusual stem cell subsets in their lungs that, together, seem to contribute to the inflammation, tissue scarring, and excessive mucus ... Read more

April 30, 2020April 30, 2020

Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

News

Triple therapy with fluticasone furoate (FF), umeclidinium (UMEC), and vilanterol (VI) can reduce mortality rates among people with chronic obstructive pulmonary disease (COPD) more than VI treatment with either ... Read more

April 27, 2020April 27, 2020

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

News, syndicated

While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands, hobbled economies worldwide and drove millions to quarantine in ... Read more

April 23, 2020April 23, 2020

American Thoracic Society Issues New Guidelines for COPD Treatments

News

New official guidelines have been published by the American Thoracic Society (ATS) for the treatment of chronic obstructive pulmonary disease (COPD). Among the new recommendations, the combination of long-acting beta ... Read more

April 16, 2020April 16, 2020

MP1032 May Protect Lungs From Oxidative Stress, COPD Model Suggests

News

MP1032, an anti-inflammatory molecule developed by MetrioPharm, inhibits the formation of 3-nitrotyrosine — a biomarker of nitrogen reactive species — induced by cigarette smoke in the air sacs of ... Read more

Pin It on Pinterest